Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Capital/Financing Update 2025

Aug 16, 2025

61842_rns_2025-08-16_a66a94c9-de62-4a90-93d6-571925149f4f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406200 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in

==> picture [189 x 71] intentionally omitted <==

Date: August 16, 2025

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1

Dear Sir/Madam,

  • Sub.: Receipt of call money in respect of first call on the outstanding 3,71,779 partly paid-up Rights Equity Shares of the Company.

  • Ref. : Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, as amended.

This is further to our intimation dated July 02, 2025, with respect to issue of First Reminder Notice dated July 01 2025, for payment of first call of Rs. 131.25 (Rupees One Hundred and Thirty-One and Paise Twenty-Five Only) per Rights Equity Share (“ First Call ”) on the outstanding 6,08,988 (Six Lakh Eight Thousand Nine Hundred Eighty-Eight) partly paid-up equity shares of the Company having a face value of Rs. 10 each with Rs.3.50 paid-up (“ Rights Equity Shares ”), which were allotted on June 19, 2024, on a rights basis pursuant to the Letter of Offer dated May 09, 2024.

In relation to the said First Reminder Notice for payment of First Call money, this is to inform that the Company has received first call money aggregating to Rs. 4,87,95,993.75/- (Rupees Four Crore Eighty-Seven Lakh Ninety-Five Thousand Nine Hundred Ninety-Three and Seventy-Five Paise only) towards of 3,71,779 Rights equity shares. Accordingly, the Rights Issue Committee of the Company (“Committee”) by way of Circular Resolution passed today i.e., on August 16, 2025, approved the conversion of 3,71,779 partly paid-up equity shares having a face value of Rs. 10 each with Rs. 3.50 paid-up and bearing ISIN IN9624Z01014 to partly paid-up equity shares having a face value of Rs.10 each with Rs.7 paid-up bearing ISIN: IN9624Z01022 (hereinafter referred to as the “Converted Rights Equity Shares”).

Post aforesaid conversion, the paid-up capital of the Company stands increased to Rs. 44,47,03,723.50/- (Rupees Forty-Four Crores Forty-Seven Lakhs Three Thousand Seven Hundred Twenty-Three and Fifty Paise only) divided into 3,61,54,267 fully paid-up equity shares having a face value of ₹ 10/- each bearing ISIN INE624Z01016, 1,17,61,546 partly paid-up Rights Equity Shares having a face value of ₹ 10/- each with Rs.7/- each paid-up bearing ISIN IN9624Z01022, and 2,37,209 partly paid-up Rights Equity Shares having a face value of ₹ 10/- each with Rs.3.5/each paid-up bearing ISIN IN9624Z01014.

The Company shall take necessary steps to make corporate actions / obtaining listing and trading approvals in respect of the Converted Rights Equity Shares.

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-2789 2924

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 47406200 Fax: +91 44 47406190 E-mail: [email protected] Website: www.solara.co.in

==> picture [189 x 71] intentionally omitted <==

This is for your information and also for the information of members and the public at large.

Thanking you,

Yours faithfully

For Solara Active Pharma Sciences Limited

POOJA JAYA Digitally signed by POOJA JAYA KUMAR KUMAR Date: 2025.08.16 12:25:52 +05'30' Pooja Jaya Kumar Company Secretary & Compliance Officer Membership No.: A57415

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-2789 2924